Dr Kate Hospice Medicare Approved Location: 1571 Highway 51 North Suite C, Arbor Vitae, Wisconsin 54568 Phone: (715) 301-7200 |
News Archive
The U.S. Food and Drug Administration today granted accelerated approval to Perjeta (pertuzumab) as part of a complete treatment regimen for patients with early stage breast cancer before surgery (neoadjuvant setting). Perjeta is the first FDA-approved drug for the neoadjuvant treatment of breast cancer.
Childhood cancer survivors typically suffer from the long-term effects of cancer treatment on physical health, and results of a new study suggest that social implications also exist, which may affect their chance of an "I do" at the altar.
Inhibition of a protein known to contribute to heart failure also appears to be protective of the heart in more acute cardiac stress injury, namely ischemia reperfusion, according to two studies conducted at the Center for Translational Medicine at Thomas Jefferson University. The studies will be presented at the American Heart Association Scientific Sessions 2009 in Orlando, Fla.
Diabetes is the fourth leading global cause of death and, with over 60 million people in Europe already estimated to have pre-diabetes, the situation is set to escalate at an alarming rate unless urgent action is taken.
› Verified 2 days ago